Point of care testing for C-reactive protein: A new path for australian GPs?

Australian Family Physician

Volumn 35, Issue 7, 2006, Pages 513-516

  Melbye, Hasse ^a   Stocks, Nigel ^b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

AUSTRALIA; BACTERIAL INFECTION; BLOOD; GENERAL PRACTICE; HOSPITAL INFORMATION SYSTEM; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; PNEUMONIA; PREDICTION AND FORECASTING; REFERENCE VALUE; RESPIRATORY TRACT INFECTION; REVIEW; SINUSITIS; VIRUS INFECTION;

AUSTRALIA; BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; FAMILY PRACTICE; HUMANS; PNEUMONIA; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; RESPIRATORY TRACT INFECTIONS; SINUSITIS; VIRUS DISEASES;

EID: 33846859247     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Gutierres SL, Welty TE. Point-of-care testing: an introduction. Ann Pharmacother 2004;38:119-25.
2. Andre M, Schwan A, Odenholt I. The use of CRP tests in patients with respiratory tract infections in primary care in Sweden can be questioned. Scand J Infect Dis 2004;36:192-7.
3. Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem 2004;279:487-90.
4. Hirschfield GM, Pepys MB. C-reactive protein and cardiovascular disease: new insights from an old molecule. QJM 2003;96:793-807.
5. Dahler-Eriksen BS, Lassen JF, Petersen PH, Lund ED, Lauritzen T, Brandslund I. Evaluation of a near patient test for C-reactive protein used in daily routine in primary healthcare by use of difference plots. Clin Chem 1997;43:2064-75.
6. Esposito S, Tremolati E, Begliatti E, Bosis S, Gualtieri L, Principi N. Evaluation of a rapid bedside test for the quantitative determination of C-reactive protein. Clin Chem Lab Med 2005;43:438-40.
7. Dahler-Eriksen BS, Lauritzen T, Lassen JF, Lund ED, Brandslund I. Near patient test for C-reactive protein in general practice: assessment of clinical, organisational and economic outcomes. Clin Chem 1999;45:478-85.
8. Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579-87.
9. Stocks NP, McElroy H, Sayer GP, Duszynski K. Acute bronchitis in Australian general practice. A prescription too far? Aust Fam Physician 2004;33:91-3.
10. Macfarlane J, Lewis SA, Macfarlane R, Holmes W. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in general practice in the UK: implications for developing management guidelines. Respir Med 1997;91:427-34.
11. Puhakka T, Makela MJ, Alanen A, et al. Sinusitis in the common cold. J Allergy Clin Immunol 1998;102:403-8.
12. Melbye H, Berdal BP, Straume B, Russell H, Vorland L, Thacker WL. Pneumonia: a clinical or radiographic diagnosis? Etiology and clinical features of lower respiratory tract infection in adults in general practice. Scand J Infect Dis 1992;24:647-55.
13. Lindbaek M, Hjortdahl P, Johnsen UL. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. BMJ 1996;313:325-9.
14. Smucny J, Fahey T, Becker L, Glazier R. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004;CD000245.
15. Melbye H. Community pneumonia: more help is needed to diagnose and assess severity. Br J Gen Pract 2002;52:886-8.
16. Lindbaek M, Hjortdahl P. The clinical diagnosis of acute purulent sinusitis in general practice: a review. Br J Gen Pract 2002;52:491-5.
17. Young J, Bucher H, Tschudi P, Periat P, Hugenschmidt C, Welge-Lussen A. The clinical diagnosis of acute bacterial rhinosinusitis in general practice and its therapeutic consequences. J Clin Epidemiol 2003;56:377-84.
18. Diehr P, Wood RW, Bushyhead J, Krueger L, Wolcott B, Tompkins RK. Prediction of pneumonia in outpatients with acute cough: a statistical approach. J Chronic Dis 1984;37:215-25.
19. Melbye H, Straume B, Aasebo U, Dale K. Diagnosis of pneumonia in adults in general practice. Relative importance of typical symptoms and abnormal chest signs evaluated against a radiographic reference standard. Scand J Prim Health Care 1992;10:226-33.
20. Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003;53:358- 64.
21. Sund-Levander M, Ortqvist A, Grodzinsky E, Klefsgard O, Wahren LK. Morbidity, mortality and clinical presentation of nursing home acquired pneumonia in a Swedish population. Scand J Infect Dis 2003;35:306- 10.
22. Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator associated pneumonia. Chest 2002;122:262-8.
23. Whicher JT, Chambers RE, Higginson J, Nashef L, Higgins PG. Acute phase response of serum amyloid A protein and C reactive protein to the common cold and influenza. J Clin Pathol 1985;38:312-6.
24. Melbye H, Hvidsten D, Holm A, Nordbo SA, Brox J. The course of C-reactive protein response in untreated upper respiratory tract infection. Br J Gen Pract 2004;54:653-8.
25. Ruuskanen O, Putto A, Sarkkinen H, Meurman O, Irjala K. C-reactive protein in respiratory virus infections. J Pediatr 1985;107:97-100.
26. Hansen JG, Schmidt H, Rosborg J, Lund E. Predicting acute maxillary sinusitis in a general practice population. BMJ 1995;311:233-6.
27. Savolainen S, Jousimies-Somer H, Karjalainen J, Ylikoski J. Do simple laboratory tests help in etiologic diagnosis in acute maxillary sinusitis.Acta Otolaryngol Suppl 1997;529:144-7.
28. Smith RP, Lipworth BJ. C-reactive protein in simple community acquired pneumonia. Chest 1995;107:1028- 31.
29. Hansson LO, Hedlund JU, Ortqvist AB. Sequential changes of inflammatory and nutritional markers in patients with community acquired pneumonia. Scand J Clin Lab Invest 1997;57:111-8.
30. Melbye H, Straume B, Brox J. Laboratory tests for pneumonia in general practice: the diagnostic values depend on the duration of illness. Scand J Prim Health Care 1992;10:234-40.
31. van dM, V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ 2005;331:26.
32. Almirall J, Bolibar I, Toran P, et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community acquired pneumonia. Chest 2004;125:1335-42.
33. Kohli V, Singhi S, Sharma P, Ganguly NK. Value of serum C-reactive protein concentrations in febrile children without apparent focus. Ann Trop Paediatr 1993;13:373-8.
34. Dev D, Wallace E, Sankaran R, et al. Value of Creactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med 1998;92:664-7.
35. Melbye H, Aaraas I, Fleten N, Kolstrup N, Mikalsen JI. The value of C-reactive protein testing in suspected lower respiratory tract infections. A study from general practice on the effect of a rapid test on antibiotic research and course of the disease in adults. Tidsskr Nor Laegeforen 1995;115:1610-5.
36. Diederichsen HZ, Skamling M, Diederichsen A, et al. Randomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice. Scand J Prim Health Care 2000;18:39-43.
37. Lindbaek M, Hjortdahl P. C-reactive protein in general practice. An important diagnostic tool in infections. Tidsskr Nor Laegeforen 1998;118:1176-9.
38. Bjerrum L, Gahrn-Hansen B, Munck AP. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract 2004;54:659-62.
39. Engstrom S, Molstad S, Lindstrom K, Nilsson G, Borgquist L. Excessive use of rapid tests in respiratory tract infections in Swedish primary health care. Scand J Infect Dis 2004;36:213-8.